Application no. and date | 05788492.6 (espacenet) (Federated) (European Patent Register), 20050927 | Patent/reg. no. and date | DK/EP 1799269, 20160907 | Publication date | 20070627 | Priority no. and date | US 613991 P, 20040928, US 658196 P, 20050302, US 703020 P, 20050726 | EP pub. no. and date |
EP 1799269 20070627 | Effective date | | Applicant/owner | Quark Pharmaceuticals, Inc., 6501 Dumbarton Circle
Fremont, California 94555, US | Applicant ref. no. | V1609-017-DK | Inventor | FEINSTEIN, Elena, 12/29 Hahagana Street
Rehovot, IL, ZURR, Daniel, 58 Yehoshua Bin Noon
Herzlia Pituach, IL, EHRLICH, Shai, 300 Menlo Court
Walnut Creek, California CA 94598, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/713 (2006.01) , C12N 15/113 (2010.01) , A61P 13/12 (2006.01) , A61P 17/14 (2006.01) , A61P 25/00 (2006.01) , A61P 27/16 (2006.01) , C07H 21/02 (2006.01) | Title | OLIGORIBONUKLEOTIDER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF TIL BEHANDLING AF ALOPECI, AKUT NYRESVIGT OG ANDRE SYGDOMME | Int. application no. | IL2005001035 | Int. publication no. | WO2006035434 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|